Document Detail


Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na/H exchange.
MedLine Citation:
PMID:  12447176     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: The preconditioning effects of the adjunctive, cardiac-specific sodium-hydrogen ion exchange inhibitor cariporide (cariporide mesilate, HOE 642) were studied in hearts subjected to 30 minutes of normothermic ischemia and reperfusion to assess myocardial and endothelial changes. METHODS: Sixteen Yorkshire-Duroc pigs (27-34 kg) receiving cardiopulmonary bypass underwent either cardiopulmonary bypass alone (control, n = 4) or 30 minutes of normothermic ischemia, followed by 30 minutes of blood reperfusion (n = 12). Six hearts were treated with 5 mg/kg cariporide administered intravenously 15 minutes before ischemia. RESULTS: Cardiopulmonary bypass alone caused no changes. Conversely, 30 minutes of global normothermic ischemia caused 33% mortality and, in survivors, depression of left ventricular function to 22% +/- 6% of baseline preload recruitable stroke work and increased creatine kinase MB by 406% (88 +/- 13 U/L), conjugated dienes by 17% (161 +/- 0.2 AU/mL), and myeloperoxidase activity by 297% (0.036 +/- 0.005 U/g). Myocardial edema developed (3.5% water gain). Coronary sinus endothelin 1 increased by 111% (2.05 +/- 0.38 pg/mL), and nitric oxide production decreased by 10%. These adverse effects were limited by pretreatment with cariporide, which allowed complete survival and restored preload recruitable stroke work to 78% +/- 11%. Measurements of creatine kinase MB, conjugated dienes, myeloperoxidase, water, and endothelin 1 returned to baseline values, and nitric oxide production was accentuated 3-fold. CONCLUSIONS: These observations show that adjunctive pretreatment with cariporide delays myocardial and endothelial injury during ischemia and reperfusion, limits oxygen-derived radical injury, restores function, reduces edema, and preserves endothelin and nitric oxide balance at normal values. The myeloperoxidase changes show that less white blood cell adherence supports reduced reperfusion endothelial damage.
Authors:
Manuel Castellá; Gerald D Buckberg; Zhongtuo Tan; Louis J Ignarro
Related Documents :
20483816 - A new data mining approach for profiling and categorizing kinetic patterns of metabolic...
1442506 - Role of perfluorochemical emulsions in the treatment of myocardial reperfusion injury.
1928216 - Myocardial injury mediated by oxygen free radicals.
8596196 - Interaction of singlet oxygen with 5'-nucleotidase in rat hearts.
1174766 - The role of h1 and h2-receptors in the coronary vascular response to histamine of isola...
3347586 - Myocardial ischemia in kawasaki disease: follow-up study by cardiac catheterization and...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  124     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-11-26     Completed Date:  2003-01-29     Revised Date:  2005-11-17    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1113-21     Citation Subset:  AIM; IM    
Affiliation:
Department of Surgery, Division of Cardiothoracic Surgery, and the Department of Physiology, University of California, Los Angeles, School of Medicine, Los Angeles, CA 90095-1701, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Anti-Arrhythmia Agents / pharmacology
Cardiopulmonary Bypass
Creatine Kinase / metabolism
Creatine Kinase, MB Form
Endothelin-1 / metabolism
Guanidines / pharmacology*
Ischemic Preconditioning, Myocardial
Isoenzymes / metabolism
Myocardial Reperfusion Injury / prevention & control*
Myocardium / metabolism
Nitric Oxide / metabolism
Peroxidase / metabolism
Sulfones / pharmacology*
Swine
Time Factors
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 0/Endothelin-1; 0/Guanidines; 0/Isoenzymes; 0/Sulfones; 0/cariporide; 10102-43-9/Nitric Oxide; EC 1.11.1.7/Peroxidase; EC 2.7.3.2/Creatine Kinase; EC 2.7.3.2/Creatine Kinase, MB Form

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alteration of gap junctions and connexins in the right atrial appendage during cardiopulmonary bypas...
Next Document:  Perioperative and postoperative course of cytokines and the metabolic activity of neutrophils in hum...